Valetudo Therapeutics LLC - 30 Apr 2025 Form 3 Insider Report for Liminatus Pharma, Inc. (LIMN)

Role: 10%+ Owner
Signature: /s/ Chris Kim
Issuer symbol: LIMN
Transactions as of: 30 Apr 2025
Net transactions value: $0
Form type: 3
Filing time: 16 Jun 2025, 21:19:16 UTC
SEC: View on sec.gov

Reporting Owners (2)

Name	Relationship	Address	Signature	Signature date	CIK
Valetudo Therapeutics LLC	10%+ Owner	6 CENTERPOINTE DR. #625, LA PALMA	/s/ Chris Kim	16 Jun 2025	0002067359
Kim Chris	Chief Executive Officer, Director, 10%+ Owner	6 CENTERPOINTE DR. #625, LA PALMA	/s/ Chris Kim	16 Jun 2025	0001972385

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	LIMN	Common Stock, par value $0.0001 per share						6,169,406	30 Apr 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of shares of Common Stock of Liminatus Pharma, Inc. held of record by Valetudo Therapeutics LLC. Mr. Chris Kim is the CEO and controlling member of Valetudo and has voting and dispositive power over, and may be deemed to be the beneficial owner of, the shares held by Valetudo. The business address of Valetudo is 6 Centerpointe Dr. #625, La Palma, CA 90623. Mr. Kim disclaims any beneficial ownership of any shares held by Valetudo except to the extent of his ultimate pecuniary interest therein.

Content

Consists of shares of Common Stock of Liminatus Pharma, Inc. held of record by Valetudo Therapeutics LLC. Mr. Chris Kim is the CEO and controlling member of Valetudo and has voting and dispositive power over, and may be deemed to be the beneficial owner of, the shares held by Valetudo. The business address of Valetudo is 6 Centerpointe Dr. #625, La Palma, CA 90623. Mr. Kim disclaims any beneficial ownership of any shares held by Valetudo except to the extent of his ultimate pecuniary interest therein.